FR2999908A1 - Orthopedic sole for shoe for allowing correction of non-physiological dynamics of foot, has hermetic envelope filled with shear thickening non Newtonian liquid that responds to constraint of dynamic pathological plantar hyperpression - Google Patents
Orthopedic sole for shoe for allowing correction of non-physiological dynamics of foot, has hermetic envelope filled with shear thickening non Newtonian liquid that responds to constraint of dynamic pathological plantar hyperpression Download PDFInfo
- Publication number
- FR2999908A1 FR2999908A1 FR1203529A FR1203529A FR2999908A1 FR 2999908 A1 FR2999908 A1 FR 2999908A1 FR 1203529 A FR1203529 A FR 1203529A FR 1203529 A FR1203529 A FR 1203529A FR 2999908 A1 FR2999908 A1 FR 2999908A1
- Authority
- FR
- France
- Prior art keywords
- shoe
- hermetic envelope
- plantar
- hyperpression
- constraint
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/28—Adapting the inner sole or the side of the upper of the shoe to the sole of the foot
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
- A43B17/02—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined wedge-like or resilient
- A43B17/026—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined wedge-like or resilient filled with a non-compressible fluid, e.g. gel, water
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1455—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
- A43B7/1464—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties with adjustable pads to allow custom fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
- A61F5/14—Special medical insertions for shoes for flat-feet, club-feet or the like
Abstract
Description
La présente invention concerne une semelle orthopédique permettant la correction de la dynamique non physiologique du pied et/ou d'une partie du corps humain. Pour corriger les désaxations qui sont personnelles il faut traditionnellement les évaluer par un examen. Celui-ci permet l'élaboration de la semelle orthopédique mais il est difficile d'apprécier au plus juste les moyens pour la correction exacte de la désaxation dynamique du pied ou d'une partie du corps humain. La semelle orthopédique est donc personnelle et parfois inadaptée à la désaxation. La semelle orthopédique selon l'invention permet de remédier à ces inconvénients. L'invention a pour objectif de parvenir à la standardisation d'un moyen thérapeutique adapté au plus juste à la désaxation pathologique permettant de traiter une patientèle n'ayant subi aucun examen. L'invention concerne en effet une semelle orthopédique ou une orthèse plantaire ou une première de chaussure caractérisée par le fait qu'une enveloppe hermétique, de forme et de taille correspondant à celle de la première de la chaussure du patient aussi bien un homme, une femme ou un enfant allant du 17 au 48 en points français et de hauteur en fonction de la pointure de la chaussure, soit remplie d'un fluide non newtonien rhéoépaississant. Les déviations d'une partie ou de l'ensemble du corps humain se traduisent par un appui plantaire pathologique. Cette appui pathologique se traduit par un transfert de charge sur une zone d'appui plantaire, il y a alors une hyperpression plantaire. Le fluide non newtonien rhéoépaississant a sa viscosité qui augmente lorsqu'on augmente le taux de cisaillement. En conséquence la semelle orthopédique conforme à l'invention est caractérisée par une réponse adéquate à l'hyperpression plantaire pathologique dynamique car celle-ci, en augmentant les contraintes sur une zone de la semelle, va augmenter la viscosité. En d'autres termes la semelle orthopédique selon l'invention se durcit en fonction de la contrainte. Cette réaction va empêcher la zone plantaire en hyperpression de pénétrer dans la semelle selon l'invention de façon pathologique et donc d'empêcher la désaxation d'une partie ou de l'ensemble du corps humain. La semelle orthopédique ou première de chaussure selon l'invention se caractérise en outre en ce que l'enveloppe hermétique contient des chambres hermétiques remplies chacune d'un fluide non newtonien rhéoépaississant, et que l'enveloppe hermétique comporte un rebord périphérique de même hauteur ou sensiblement inférieur ou supérieur.The present invention relates to an orthopedic insole for correcting the non-physiological dynamics of the foot and / or part of the human body. To correct the misalignments which are personal, it is necessary traditionally to evaluate them by an examination. This allows the elaboration of the orthopedic insole but it is difficult to appreciate just the means for the exact correction of the dynamic dislocation of the foot or a part of the human body. The orthopedic insole is therefore personal and sometimes unsuited to the misalignment. The orthopedic insole according to the invention overcomes these disadvantages. The object of the invention is to achieve the standardization of a therapeutic means adapted as accurately as possible to the pathological misalignment making it possible to treat a patient who has not undergone any examination. The invention relates in fact to an orthopedic insole or a plantar orthosis or a first shoe characterized in that a hermetic envelope of shape and size corresponding to that of the first of the shoe of the patient as well a man, a woman or child ranging from 17 to 48 in French points and height depending on the size of the shoe, be filled with a non-Newtonian rheo-thickening fluid. Deviations from part or all of the human body result in pathological plantar support. This pathological support results in a transfer of load on a plantar support zone, there is then a plantar hyperpressure. The non-Newtonian rheo-thickening fluid has its viscosity which increases when the shear rate is increased. Consequently, the orthopedic insole according to the invention is characterized by an adequate response to dynamic pathological plant pressure hyperpressure, because this, by increasing the stresses on an area of the sole, will increase the viscosity. In other words, the orthopedic insole according to the invention hardens as a function of the stress. This reaction will prevent the hyperpressure plantar zone from penetrating the sole of the invention in a pathological manner and thus prevent the misalignment of part or all of the human body. The orthopedic insole or shoe insole according to the invention is further characterized in that the hermetic envelope contains hermetic chambers each filled with a non-Newtonian rheo-thickening fluid, and that the hermetic envelope comprises a peripheral rim of the same height or significantly lower or higher.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1203529A FR2999908A1 (en) | 2012-12-20 | 2012-12-20 | Orthopedic sole for shoe for allowing correction of non-physiological dynamics of foot, has hermetic envelope filled with shear thickening non Newtonian liquid that responds to constraint of dynamic pathological plantar hyperpression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1203529A FR2999908A1 (en) | 2012-12-20 | 2012-12-20 | Orthopedic sole for shoe for allowing correction of non-physiological dynamics of foot, has hermetic envelope filled with shear thickening non Newtonian liquid that responds to constraint of dynamic pathological plantar hyperpression |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2999908A1 true FR2999908A1 (en) | 2014-06-27 |
Family
ID=47989044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1203529A Withdrawn FR2999908A1 (en) | 2012-12-20 | 2012-12-20 | Orthopedic sole for shoe for allowing correction of non-physiological dynamics of foot, has hermetic envelope filled with shear thickening non Newtonian liquid that responds to constraint of dynamic pathological plantar hyperpression |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2999908A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2549670A (en) * | 2013-03-14 | 2017-10-25 | Profoot Inc | Footwear, insoles, inserts, kits and methods |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4777739A (en) * | 1980-08-26 | 1988-10-18 | Hamilton Kent Manufacturing Company, Inc. | Shock absorbing structures |
US5667895A (en) * | 1991-10-01 | 1997-09-16 | Jenkner; Brian D. | Shock attenuation device |
US6701529B1 (en) * | 1999-02-05 | 2004-03-09 | Extrude Hone Corporation | Smart padding system utilizing an energy absorbent medium and articles made therefrom |
EP1902639A1 (en) * | 2006-09-22 | 2008-03-26 | Academisch Ziekenhuis Maastricht | A footwear component, such as a sole, insole or insert, a method for designing and/or manufacturing a footwear component and a shoe |
US20080189983A1 (en) * | 2007-02-12 | 2008-08-14 | Edward Frederick | Dynamically moderated shock attenuation system for footwear |
-
2012
- 2012-12-20 FR FR1203529A patent/FR2999908A1/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4777739A (en) * | 1980-08-26 | 1988-10-18 | Hamilton Kent Manufacturing Company, Inc. | Shock absorbing structures |
US5667895A (en) * | 1991-10-01 | 1997-09-16 | Jenkner; Brian D. | Shock attenuation device |
US6701529B1 (en) * | 1999-02-05 | 2004-03-09 | Extrude Hone Corporation | Smart padding system utilizing an energy absorbent medium and articles made therefrom |
EP1902639A1 (en) * | 2006-09-22 | 2008-03-26 | Academisch Ziekenhuis Maastricht | A footwear component, such as a sole, insole or insert, a method for designing and/or manufacturing a footwear component and a shoe |
US20080189983A1 (en) * | 2007-02-12 | 2008-08-14 | Edward Frederick | Dynamically moderated shock attenuation system for footwear |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2549670A (en) * | 2013-03-14 | 2017-10-25 | Profoot Inc | Footwear, insoles, inserts, kits and methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4218484A3 (en) | Sole structure for article of footwear | |
MX2009008885A (en) | Reinforced stocking or sock for the prevention and/or treatment of hallux valgus. | |
FR2999908A1 (en) | Orthopedic sole for shoe for allowing correction of non-physiological dynamics of foot, has hermetic envelope filled with shear thickening non Newtonian liquid that responds to constraint of dynamic pathological plantar hyperpression | |
GB2497370B (en) | Footwear/insole for footwear | |
Triantafyllopoulos et al. | EMAS position statement: the management of postmenopausal women with vertebral osteoporotic fracture | |
Sokolovic et al. | OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device | |
Gurin | Calcineurin inhibitor-induced pain syndrome with stress fractures: case report | |
Wagner | Penile angioedema progressing to the oropharynx: case report | |
Lachapelle | Ankle swelling and exercise-induced vasculitis: case report | |
Mercuri et al. | DMD-TREATMENT: EP. 142 Age at loss of ambulation in patients with DMD from the STRIDE Registry and the CINRG Natural history study: a matched cohort analysis | |
Yu et al. | Management of hypertension in patients with chronic kidney disease | |
Smith et al. | Extensive Dystrophic Calcinosis Cutis: A Severe Complication of Polymyositis/Systemic Sclerosis Overlap Syndrome | |
Mena et al. | Confirmation of the pleuroperitoneal leak origin with a SPECT-CT in a patient on peritoneal dialysis | |
Reuter | Elevated transaminases and gamma-glutamyltransferase: 5 case reports | |
Al-Azzani | Alendronic acid/ciprofloxacin/ibandronic acid/prednisolone | |
Zygmunt et al. | DMD-TREATMENT: EP. 143 Assessment of patients on Eteplirsen (Exondys 51) therapy using real world data | |
Zgircea et al. | Susceptibility of periotest values in dependence of implants superstructures | |
Alonso-Navarro | Cataplexy: case report | |
Valverde-Megias | Bevacizumab/triamcinolone | |
Akcay Yalbuzdag | Zoledronic acid | |
Westberry et al. | Zellweger syndrome: An older child with progressive foot deformity | |
Whitt et al. | Foot Biomechanics for the treatment and prevention of diabetic foot ulcers | |
Ceccato | Pasireotide/temozolomide | |
Pinto Ferreira | Cushingoid habitus and hyperosmolar hyperglycaemic state: case report | |
Sampaio | Amphotericin B liposomal/itraconazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20160831 |